Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Anticancer Research|August 9, 2015
Efficacy of Combination Chemotherapy Using a Novel Oral Chemotherapeutic Agent, TAS-102, with Oxaliplatin on Human Colorectal and Gastric Cancer XenograftsMamoru Nukatsuka, Fumio Nakagawa, Teiji Takechi
Oncology Letters|July 12, 2017
Trifluridine/tipiracil increases survival rates in peritoneal dissemination mouse models of human colorectal and gastric cancerNorihiko Suzuki, Fumio Nakagawa, Teiji Takechi
Chemotherapy|February 3, 2018
Antitumor Efficacy of Combination Therapy Consisting of S-1, Leucovorin, and Oxaliplatin against Human Gastric Cancer XenograftsHideki Nagase, Fumio Nakagawa, Junji Uchida
Oncology Letters|May 14, 2021
Erratum: Trifluridine/tipiracil increases survival rates in peritoneal dissemination mouse models of human colorectal and gastric cancerNorihiko Suzuki, Fumio Nakagawa, Teiji Takechi
Experimental and Therapeutic Medicine|September 15, 2012
Trifluorothymidine exhibits potent antitumor activity via the induction of DNA double-strand breaksNorihiko Suzuki, Fumio Nakagawa, Mamoru Nukatsuka, et al.
The Journal of Laryngology and Otology|June 14, 2003
Surgical intervention in middle-ear cholesterol granulomaManabu Maeta, Ryusuke Saito, Fumio Nakagawa, et al.
Oncology Reports|November 3, 2016
Effect of a novel oral chemotherapeutic agent containing a combination of trifluridine, tipiracil and the novel triple angiokinase inhibitor nintedanib, on human colorectal cancer xenograftsNorihiko Suzuki, Fumio Nakagawa, Kazuaki Matsuoka, et al.
Oncotarget|March 24, 2018
Trifluridine/tipiracil overcomes the resistance of human gastric 5-fluorouracil-refractory cells with high thymidylate synthase expressionKazuaki Matsuoka, Fumio Nakagawa, Takashi Kobunai, et al.
Oncology Reports|January 14, 2004
Thymidine kinase and thymidine phosphorylase level as the main predictive parameter for sensitivity to TAS-102 in a mouse modelTomohiro Emura, Fumio Nakagawa, Akio Fujioka, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 31, 2002
[Antimetastatic and antitumor effects of fluoropyrimidines alone and combined with taxanes in a murine model of breast cancer metastatic to the lung]Mamoru Nukatsuka, Akio Fujioka, Fumio Nakagawa, et al.
Pageof 5